Primary Record
Buparlisib
- In stock
- 5,432 g
- Purity
- 98.5 %
- CAS
- 944396-07-0
Compound Identifiers & Properties
- CAS
- 944396-07-0
- PubChem CID
- 16654980
- SMILES
- C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4
- Canonical SMILES
- Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1
Names & Synonyms
- Buparlisib
- 944396-07-0
- NVP-BKM120
- BKM120
- NVP-BKM-120
- BKM-120
- buparlisibum
- Buparlisib [INN]
- 5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
- BKM 120
- Buparlisib (BKM120)
- NVP-BKM 120
- Buparlisib [USAN:INN]
- 3sd5
- BKM-120NX
- BKM120-NX
- Buparlisib (USAN/INN)
- RefChem:570492
- 0ZM2Z182GD
- BUPARLISIB [USAN]
- UNII-0ZM2Z182GD
- BKM 120NX
- MFCD18251596
- D01QSO
- PI3K Inhibitor BKM120
- 1202777-78-3
- C18H21F3N6O2
- BKM120-AAA
- BUPARLISIB [WHO-DD]
- QCR-4
- CHEMBL2017974
- cc-258
- MLS006010984
- SCHEMBL146956
- DTXSID50241486
- BKM120 (NVP-BKM120, Buparlisib)
- CWHUFRVAEUJCEF-UHFFFAOYSA-N
- GTPL7878
- orb1307367
- BKM120,NVP-BKM120
- SCHEMBL29350945
- SCHEMBL29351351
- SCHEMBL29387968
- AMMD00049
- CHEBI:71954
- CTK8C0567
- 944396-07-0 (free base)
- BKM-120 (PI3K)
- BMK-120
- DTXCID50163977
- EX-A189
- SYN1200
- GLXC-90108
- HMS3295I15
- HMS3655D16
- AOB87379
- BKM120 (NVP-BKM120)
- BKM120 - NVP-BKM120
- ABP000735
- AN2025
- ANW-64908
- BDBM50380363
- NSC754353
- NSC799370
- s2247
- ZINC43154039
- AKOS016005372
- ACN-031536
- AM85983
- BCP9001011
- CCG-264954
- CS-0089
- DB11666
- EBC-220039
- FD64903
- NSC-754353
- NSC-799370
- RL05935
- SB16577
- SDCCGSBI-0654414.P001
- Buparlisib (BKM120, NVP-BKM120)
- 5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine
- NCGC00262604-01
- NCGC00262604-08
- 4CA-0929
- AC-32077
- AC-35575
- AK103313
- AN-26178
- AS-40568
- BC638775
- BKM120 (NVP-BKM120, Buparlisib)?
- CID:16654980
- HY-70063
- SMR004702786
- SY078482
- 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine
- SID:160778579
- AB0008183
- AJ-108243
- DB-079882
- ST2411649
- TC-153653
- A3015
- FT-0755923
- NS00072516
- SW218149-2
- X7578
- J3.281.564B
- KS-00000637
- A11016
- A25436
- D10584
- W-5735
- 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine
- 5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine
- A892274
- C571178
- BRD-K42191735-001-01-2
- BRD-K42191735-001-05-3
- BRD-K42191735-001-08-7
- Q25100534
- 5-[2,6-bis(morpholin-4-yl)pyrimidin-4-yl]-4-(trifluoromethyl)pyridin-2-amine
- Buparlisib, 98%, a selective PI3K inhibitor - 1G 1g
- B0084-438224
- 2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-
- 2-Pyridinamine,5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-
- 4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine
- 5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine.
- 2,4-Bismorpholino-6-[4-(trifluoromethyl)-6-aminopyridin-3-yl]pyrimidine
- 2-Amino-4-(trifluoromethyl)-5-[2,4-bismorpholinopyrimidine-6-yl]pyridine
- 4-(Trifluoromethyl)-5-(2,6-dimorpholino-4-pyrimidinyl)-2-pyridineamine
- 4-Trifluoromethyl-5-(2,6-di(4-morpholinyl)-4-pyrimidinyl)pyridine-2-amine
- 5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine
- (4-Trifluoromethyl-5-[2,4-di(4-morpholinyl)pyrimidine-6-yl]pyridin-2-yl)amine
- 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine
- BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120
- SD5